CREBBP |
CREBBP, CBP: CREB-binding protein |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
22.500 |
Evidence |
|
HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
22.450 |
Evidence |
|
RELA |
RELA, NFKB3: Transcription factor p65 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
22.450 |
Evidence |
|
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
22.450 |
Evidence |
|
PRKAB2 |
PRKAB2: 5'-AMP-activated protein kinase subunit beta-2 |
PRKAG2 |
PRKAG2: 5'-AMP-activated protein kinase subunit gamma-2 |
22.430 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
22.430 |
Evidence |
O
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
22.430 |
Evidence |
O
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
22.350 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
SOS1 |
SOS1: Son of sevenless homolog 1 |
22.350 |
Evidence |
O
|
SSH1 |
SSH1, KIAA1298, SSH1L: Protein phosphatase Slingshot homolog 1 |
CFL2 |
CFL2: Cofilin-2 |
22.350 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
22.350 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
22.350 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
22.290 |
Evidence |
|
PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
CRKL |
CRKL: Crk-like protein |
22.290 |
Evidence |
O
|
JUN |
JUN: Transcription factor AP-1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
22.290 |
Evidence |
O
|
INSR |
INSR: Insulin receptor precursor |
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
22.290 |
Evidence |
|
ITGB3 |
ITGB3, GP3A: Integrin beta-3 precursor |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
22.290 |
Evidence |
|
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
TGFBR2 |
TGFBR2: TGF-beta receptor type-2 precursor |
22.290 |
Evidence |
|
CD74 |
IPI00217775 |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
22.260 |
Evidence |
|
CD74 |
IPI00217775 |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
22.260 |
Evidence |
|
SIGIRR |
SIGIRR, UNQ301/PRO342: Single Ig IL-1-related receptor |
TLR5 |
IPI00656104 |
22.200 |
Evidence |
|
KCNJ3 |
KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 |
KCNJ9 |
KCNJ9, GIRK3: G protein-activated inward rectifier potassium channel 3 |
22.200 |
Evidence |
O
|
JUN |
JUN: Transcription factor AP-1 |
RB1 |
RB1: Retinoblastoma-associated protein |
22.040 |
Evidence |
O
|
SOS1 |
SOS1: Son of sevenless homolog 1 |
CD2AP |
CD2AP: CD2-associated protein |
21.650 |
Evidence |
|
TLR1 |
TLR1, KIAA0012: Toll-like receptor 1 precursor |
TLR10 |
IPI00556077 |
21.590 |
Evidence |
|